A study to see the action of Lycopodium 200 on Diabetic Polyneuropathy.
Phase 3
Completed
- Conditions
- Health Condition 1: E114- Type 2 diabetes mellitus with neurological complications
- Registration Number
- CTRI/2023/02/049847
- Lead Sponsor
- Dr. Simran Samdani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Both male and female suffering from diabetes mellitus on allopatic management.
DDSPSAS >2
DNE >1
Controlled hypertension.
Previously diagnosed case.
Written informed consent.
Exclusion Criteria
Diabetic Mononeuropathy, polyradiculopathy, amyothrophy, autonomic neuropathy, abnormalities of gait,wrist/foot drop, paralysis of cranial nerves.
MI within 6 months, unstable angina.
Neuropathy due to other causes, Vit B12 deficiency, alcoholism
Diabetic complications- retinopathy, renal involvement, recurrent hypoglycemia, ketoacidosis.
Other systemic disease- CVS , endocrinal, systemic infections or on other treatment (except HTN)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the role of Lycopodium 200 homeopathic medicine in management of DDSPTimepoint: DNE (Diabetic Neuropathy Examination )will be done at baseline and every 2 weeks follow up in order to assess the effect of <br/ ><br>homeopathic medicine Lycopodium 200 in DDSP
- Secondary Outcome Measures
Name Time Method To assess the change in the DNE score before and after homoeopathic treatment in management of DDSPTimepoint: DNE (Diabetic Neuropathy Examination )will be done at every 2 weeks follow up in order to assess the effect of <br/ ><br>homeopathic medicine Lycopodium 200 in DDSP